Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib vs Diclofenac in Chronic Low Back Pain
NCT00090181Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2004
- Primary completion
- Mar 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of etoricoxib in chronic low back pain (CLBP) (2 arms), sponsored by Organon & Co. Primary endpoints: Low Back Pain Intensity Scale at 4 weeks and Safety and tolerability at 4 weeks. Started Jun 2004; status: completed.
02
Drugs
etoricoxib
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00090181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090181.